Pillstats
Tablet

Sulfamethoxazole And Trimethoprim

Sulfamethoxazole + Trimethoprim

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)198334
US makers1 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.011$0.023$0.034$0.046Dec 2025Apr 2026Jul 2026
$0.039
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K42K57K2025 Q12025 Q22025 Q32025 Q42026 Q1
42K
Rx · 2026 Q1
1.0M
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown6SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 7, 2021
    RECALLRecall (Class II): Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, Distributed by: Aur…

    Presence of Foreign Substance- Potential of metal contamination. — Recalling firm: Aurobindo Pharma USA Inc. — Nationwide

  • Aug 10, 2020
    RECALLRecall (Class II): Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distrib…

    Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s). — Recalling firm: Aurobindo Pharma USA Inc. — Nationwide in the U.S.